Aiidera FHIR-definitioner
0.22.0 - Draft
Aiidera FHIR-definitioner 0.22.0, utkast. Utgiven av Aiidera på fhir.aiidera.se. Varje publicerad utgåva ligger kvar under sin version, som fhir.aiidera.se/0.22.0.
| Draft as of 2026-11-18 |
{
"resourceType" : "ValueSet",
"id" : "aiidera-umi-behandling-atc",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Genererad berättande text: ValueSet aiidera-umi-behandling-atc</b></p><a name=\"aiidera-umi-behandling-atc\"> </a><a name=\"hcaiidera-umi-behandling-atc\"> </a><ul><li>Include dessa koder enligt definitionen i <a href=\"http://www.whocc.no/atc\"><code>http://www.whocc.no/atc</code></a><span title=\"Versionen är inte uttryckligen angiven. Ingen matchande Kodsystem hittades\"> version Ej angiven (använd senaste från terminologiserver)</span><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Kod</b></td><td><b>Visning</b></td></tr><tr><td>B01AA</td><td>Vitamin K-antagonister</td></tr><tr><td>B01AA03</td><td>Warfarin</td></tr><tr><td>B01AB</td><td>Heparingruppen</td></tr><tr><td>B01AE</td><td>Direkt trombinhämmande medel</td></tr><tr><td>B01AF</td><td>Direktverkande faktor Xa-hämmare</td></tr><tr><td>L01</td><td>Antineoplastiska medel</td></tr><tr><td>L03A</td><td>Immunstimulerande medel</td></tr><tr><td>L04</td><td>Immunsuppressiva medel</td></tr></table></li></ul></div>"
},
"url" : "https://fhir.aiidera.se/ValueSet/aiidera-umi-behandling-atc",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:1.2.752.116.3.1.16.1.2.2"
}
],
"version" : "0.22.0",
"name" : "AiideraUmiBehandlingAtc",
"title" : "Behandling — ATC-urvalet",
"status" : "draft",
"experimental" : false,
"date" : "2026-11-18T13:57:18+00:00",
"publisher" : "Aiidera",
"contact" : [
{
"name" : "Aiidera",
"telecom" : [
{
"system" : "email",
"value" : "fhir@aiidera.se"
}
]
}
],
"description" : "ATC-urvalet 1.2.752.116.3.1.16.1.2.2 för undergruppen Behandling. Koderna och benämningarna står som i kodverkslistan 6.1.2, bladet Behandling.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "SE",
"display" : "Sweden"
}
]
}
],
"compose" : {
"include" : [
{
"system" : "http://www.whocc.no/atc",
"concept" : [
{
"code" : "B01AA",
"display" : "Vitamin K-antagonister"
},
{
"code" : "B01AA03",
"display" : "Warfarin"
},
{
"code" : "B01AB",
"display" : "Heparingruppen"
},
{
"code" : "B01AE",
"display" : "Direkt trombinhämmande medel"
},
{
"code" : "B01AF",
"display" : "Direktverkande faktor Xa-hämmare"
},
{
"code" : "L01",
"display" : "Antineoplastiska medel"
},
{
"code" : "L03A",
"display" : "Immunstimulerande medel"
},
{
"code" : "L04",
"display" : "Immunsuppressiva medel"
}
]
}
]
}
}